1. Pink Sheet
  2. >>Vaccines

COVID Vaccines, School Reopenings, And Sticking To The Script

 
• By Nielsen Hobbs

US House hearing on coronavirus vaccines produces little drama, but a question on school reopenings underscores the difficult position that industry finds itself in during the pandemic – and how its more routine business model has deep challenges as well.

House Energy and Commerce/Oversight and Investigations Subcommittee hearing on COVID vaccines, 21 July 2020
The vaccine bunch – participants in the House Energy and Commerce/Oversight and Investigations Subcommittee hearing on COVID vaccines, 21 July 2020. Clockwise from the top left: Moderna’s Stephen Hoge, Pfizer’s John Young, Johnson & Johnson’s Macaya Douoguih, AstraZeneca’s Mene Pangalos, Merck’s Julie Gerberding, Rep. Raul Ruiz (D-CA), Rep. David McKinley (R-WV), a masked Rep. Greg Walden (R-OR), and in the center square, subcommittee chair Diana DeGette (D-CO) is pictured swearing in the witnesses. • Source: photo illustration from screenshots of hearing feed

The US House hearing examining vaccines to prevent COVID-19 on 21 July stuck almost entirely to the script: Democrats criticized the Trump administration’s response to the pandemic, Republicans offered contrary statistics, and witnesses from industry said their decisions would be guided by science.

Those hoping for fireworks were likely disappointed. Colorado Representative Diana DeGette, chair of the House Energy and Commerce/Oversight and Investigations...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

New CDC Vaccine Panel Chair Vows To ‘Rebuild Public Trust’ With Evidence-Based Medicine

 
• By Sue Sutter

The newly reconstituted Advisory Committee on Immunization Practices will create new work groups to examine the cumulative impact of vaccine schedules and reexamine some older vaccines.

Cassidy Confirms Agreement With Kennedy Did Not Include Maintaining CDC Vaccine Advisors

 
• By Sarah Karlin-Smith

Sen. Bill Cassidy and HHS Secretary Robert F. Kennedy Jr. agree the disbanding of ACIP did not violate their agreement, but the perception that Kennedy is not following the spirit of the pledge could be more important long-term.

ACIP Members ‘Not Easy’ To Find After Clean Sweep, US CDC Director Nominee Says

 
• By Cathy Kelly

The CDC Advisory Committee on Immunization Practices had only seven members in place as it met for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed the previous panelists. CDC Director nominee Susan Monarez said finding replacements has been difficult.

BIO CEO On Industry And US FDA, Trump’s Vaccine Views And MFN Counter Proposals

 
• By Sarah Karlin-Smith

John Crowley discussed how he prioritizes industry’s many competing challenges in a Pink Sheet interview at the BIO International Convention.

More from Pink Sheet

New CDC Vaccine Panel Chair Vows To ‘Rebuild Public Trust’ With Evidence-Based Medicine

 
• By Sue Sutter

The newly reconstituted Advisory Committee on Immunization Practices will create new work groups to examine the cumulative impact of vaccine schedules and reexamine some older vaccines.

Cassidy Confirms Agreement With Kennedy Did Not Include Maintaining CDC Vaccine Advisors

 
• By Sarah Karlin-Smith

Sen. Bill Cassidy and HHS Secretary Robert F. Kennedy Jr. agree the disbanding of ACIP did not violate their agreement, but the perception that Kennedy is not following the spirit of the pledge could be more important long-term.

ACIP Members ‘Not Easy’ To Find After Clean Sweep, US CDC Director Nominee Says

 
• By Cathy Kelly

The CDC Advisory Committee on Immunization Practices had only seven members in place as it met for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed the previous panelists. CDC Director nominee Susan Monarez said finding replacements has been difficult.